On February 20,2025, Mr.Yu Jung-mao, Executive Director of KP Health Technology, Mr.Yang Junhu, director, Representative Director of PARK JAESANG DS INDUS and Mr.Li Jin-hao, executive Director of E 2 BIO subsidiary of Ewha University, visited AGBA & SME Asia Pacific headquarters for a friendly visit and in-depth cooperation and exchange.

(Second from left: Mr.Yu Jung-mao, Executive Director of KP Health Technology Co., Ltd., third from left: Representative Director of PARK JAESANG DS INDUS, first from right: Mr.Yang Jun-ho, Director of KP Health Technology Co., Ltd.; Mr.Li Jin-ho, Executive Director of E 2 BIO, subsidiary of Ewha University)

KP Health Technology is a comprehensive enterprise driven by scientific and technological innovation and committed to providing users with healthier and better products and service experience through diversified products and services. The visit to AGBA & SME Asia Pacific headquarters aims to further explore the company's optimization path in terms of business market positioning, long-term development strategic layout and capital market objectives, so as to achieve a higher level of development breakthrough.

During the meeting, the two sides had in-depth discussions on key topics such as KP Health Technology's business market positioning, innovative operation mode, long-term business development strategy and layout, resource integration between China and South Korea, and capital market objectives. With its professional experience and rich resources in the field of overseas marketing guidance, AGBA & SME has provided comprehensive strategic cooperation and development advice for KP Health Technology. Through accurate market analysis, professional capital operation plan and efficient resource integration ability, it provides a clear idea and feasible implementation path for the coordinated development of KP health technology business in the Chinese and Korean market.

The head of AGBA & SME Asia Pacific headquarters said at the conference, " AGBA & SME has been committed to providing a full range of consulting services and capital operation solutions to help enterprises maximize their value in the international capital market. The cooperation with KP Health Technology is an important practice for us to serve Chinese and South Korean enterprises and promote regional economic cooperation. We believe that through the in-depth cooperation, the two sides can give full play to their advantages in their respective fields, share resources and complement each other, and jointly open up a new situation for the interconnected development of China and the ROK.”

Mr.Yu Jung-mau, Executive Director of KP Health Technology, Korea, spoke highly of the professional ability and service concept in the field of AGBA & SME listing. He said: " Korea Corporation KP Health Technology has always been committed to providing users with a healthier and better product and service experience. AGBA & SME's professional strength and rich experience in the field of overseas listing guidance provide us with extremely valuable strategic advice and development direction. We look forward to the in-depth cooperation with AGBA & SME, further enhance the competitiveness of KP Health Technology in the international market through resource integration and capital market layout, and achieve win-win development of both sides.”

This meeting not only laid a solid foundation for the coordinated development of KP Health Technology in the Chinese and South Korean markets, but also further demonstrated the core value and strategic role of AGBA & SME in the field of overseas listing guidance. In the future, AGBA & SME will continue to rely on its professional advantages to help more Chinese and South Korean enterprises to realize resource sharing and complementary advantages, promote Sino-South Korean economic cooperation to a higher level and a wider field, and inject new impetus into the prosperity and development of regional economy. At the same time, AGBA & SME will also be committed to serving more Asian companies to land in the US capital market, helping them to enhance their international influence, optimize their global business layout, and achieve the strategic goal of international development.